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Abstract
The rostromedial tegmental nucleus (RMTg), also called the GABAergic tail of the ventral
tegmental area, projects to the midbrain dopaminergic system, dorsal raphe nucleus, locus
coeruleus, and other regions. Whether the RMTg is involved in sleep–wake regulation is
unknown. In the present study, pharmacogenetic activation of rat RMTg neurons promoted
non-rapid eye movement (NREM) sleep with increased slow-wave activity (SWA). Con-
versely, rats after neurotoxic lesions of 8 or 16 days showed decreased NREM sleep with
reduced SWA at lights on. The reduced SWA persisted at least 25 days after lesions. Simi-
larly, pharmacological and pharmacogenetic inactivation of rat RMTg neurons decreased
NREM sleep. Electrophysiological experiments combined with optogenetics showed a direct
inhibitory connection between the terminals of RMTg neurons and midbrain dopaminergic
neurons. The bidirectional effects of the RMTg on the sleep–wake cycle were mimicked by
the modulation of ventral tegmental area (VTA)/substantia nigra compacta (SNc) dopami-
nergic neuronal activity using a pharmacogenetic approach. Furthermore, during the 2-hour
recovery period following 6-hour sleep deprivation, the amount of NREM sleep in both the
lesion and control rats was significantly increased compared with baseline levels; however,
only the control rats showed a significant increase in SWA compared with baseline levels.
Collectively, our findings reveal an essential role of the RMTg in the promotion of NREM
sleep and homeostatic regulation.
Author summary
Sleep–wake behavior is controlled by networks of neurons and neurotransmitters in the
brain. There are multiple populations of wake-promoting neurons, but few sleep-promot-
ing neurons have been identified. In this study, we revealed that the rostromedial tegmen-
tal nucleus, the GABAergic tail of the ventral tegmental area, regulates non-rapid eye
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movement sleep. We show that neurons in the rat rostromedial tegmental nucleus, when
activated by pharmacogenetics, increase and deepen non-rapid eye movement sleep. Inhi-
bition of these neurons exhibits the opposite effects. Furthermore, rats with lesion in the
rostromedial tegmental nucleus have a reduced response of sleep homeostasis following
sleep deprivation. We show that stimulation of the terminals of the neurons in the rostro-
medial tegmental nucleus inhibits dopaminergic neurons in the midbrain. Interestingly,
inhibition of these dopaminergic neurons also has sleep-promoting effects. The current
results provide a potential target for prolonging non-rapid eye movement sleep, improv-
ing sleep quality, and treating sleep disorders in dopamine-implicated mental illness.
Introduction
Dopamine (DA) produced by neurons in the midbrain plays a key role in processing reward,
aversive, and cognitive signals [1]. Abnormal DA is closely associated with neuropsychiatric
disorders such as Parkinson disease, schizophrenia, and substance abuse. Severe sleep distur-
bances have been observed in nearly all of these types of patients [2–5]. Growing evidence sug-
gests that DA-containing neurons are important for arousal maintenance in both humans [6,
7] and animals [8–11]. Moreover, it has been found that activation of ventral tegmental area
(VTA) γ-amino-butyric acid (GABA) neurons, which indirectly inhibits the firing of VTA
DAergic neurons, is sufficient to elicit a place aversion [12, 13]. This suggests that the ability of
midbrain DAergic neurons to regulate sleep–wake behavior and sleep problems in DA-associ-
ated mental illnesses may be affected by upstream inhibitory neuronal systems.
The rostromedial tegmental nucleus (RMTg) is a newly identified structure in the brain-
stem that is rich in μ-opioid receptors. It primarily comprises GABAergic neurons that are dis-
tributed dorsolateral to the interpeduncular nucleus (IPN). The RMTg is strikingly innervated
by the afferent input from the lateral habenula and additional inputs from the extended amyg-
dala and other closely connected regions, such as the lateral septum and periaqueductal gray
matter. The GABAergic axons from the RMTg densely project to midbrain DAergic neurons
[14–18]. The RMTg acts as a hub converging and integrating widespread signals toward DAer-
gic systems [19]. Neuroanatomical and electron microscopic studies have found that most
RMTg axons form symmetric synapses with tyrosine hydroxylase (TH)-containing dendrites
in the substantia nigra compacta (SNc) and VTA [20, 21]. An in vivo electrophysiological
study showed that the RMTg exerted greater inhibition of the SNc DAergic neurons than the
inhibitory afferents arising from the striatum, globus pallidus, or substantia nigra parsreticu-
lata [20, 22, 23]. Likewise, GABAergic RMTg neurons inhibited the activity of VTA DAergic
cells by inhibiting synaptic transmission more effectively than intermediate GABAergic neu-
rons in the VTA [21, 24, 25]. DAergic cells are controlled by excitatory and inhibitory inputs
whose balance finely tunes cell activity [26]. The RMTg is now recognized as a GABA brake
for midbrain DAergic systems [19].
Aside from the heavy output to the midbrain DAergic neurons, the RMTg sends projec-
tions to the dorsal raphe nucleus (DRN), pedunculopontine tegmental and laterodorsal teg-
mental nuclei (PPT, LDT), and locus coeruleus (LC) and has relatively meager output to the
forebrain, including the lateral hypothalamus and lateral preoptic area [14, 15]. Generally, neu-
rons in these cell groups fire most actively during wakefulness [7].
Although the RMTg has been confirmed to inhibit the electrical activity of midbrain DAer-
gic neurons associated with wakefulness activation, whether it is implicated in sleep–wake
behavior is unknown. Considering that RMTg neurons are prominently GABAergic and are
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thus speculated to inhibit rather than facilitate the activity of targeted neurons, we propose
that the RMTg is involved in promoting sleep. To test this hypothesis, we employed pharmaco-
genetics using designer receptors exclusively activated by designer drugs (DREADDs) [27]
and pharmacological approaches to manipulate neuronal activity, neurochemistry, electro-
physiology, and immunohistochemistry along with optogenetics and transgenic mice to inves-
tigate whether the RMTg plays a role in the regulation of sleep and homeostasis. We then
explored whether the RMTg nucleus controls sleep through the modulation of DAergic neu-
ron activity.
Results
Activation of RMTg neurons by hM3Dq promoted non-rapid eye
movement (NREM) sleep in rats
To test the effects of RMTg neuron activation on sleep and waking regulation, adeno-associ-
ated virus (AAV) vectors containing excitatory modified muscarinic G protein-coupled recep-
tors (hM3Dq) (Fig 1A) were bilaterally microinjected into the rat RMTg (Fig 1B). Cell-surface
expression of hM3Dq receptors was observed via red fluorescent mCherry protein. Confocal
images of double labeling with mCherry and GABA immunofluorescence showed that 87% of
mCherry-positive neurons in the RMTg region coexpressed GABA (245 of 280), which indi-
cated GABAergic neurons in the RMTg were targeted. Moreover, we found 56% of GABA-
positive neurons colabeled hM3Dq/mCherry (245 of 437) (Fig 1C and 1D), indicating that the
virus was efficient for RMTg neurons.
Immunohistochemistry showed that clozapine-N-oxide (CNO, 0.3 mg/kg), a specific
hM3Dq agonist (Fig 1E), but not saline (Fig 1F), could drive c-Fos expression in hM3Dq-
expressing neurons in the RMTg. Confocal image of double labeling with mCherry and c-Fos
immunofluorescence showed that the 56% of mCherry-positive neurons in the RMTg region
expressed c-Fos in the CNO group compared to 2% in the saline group (Fig 1G). In addition,
bath application of CNO (500 nM) depolarized the RMTg hM3Dq-expressing neurons and
significantly increased the firing of action potentials in hM3Dq/mCherry-positive neurons, as
indicated by whole-cell current clamp recordings (Fig 1H–1K). Thus, the DREADD system
used in this study stimulates the activity of rat RMTg neurons both in vivo and in vitro.
On average, the CNO-injected rats showed a 32.2% increase in non-rapid eye movement
(NREM) sleep and reductions of 84.6% and 34.8% in rapid eye movement (REM) sleep and wake-
fulness, respectively, during the 7-hour post-CNO injection period (Fig 2A and 2B). The number
of stage conversions from wakefulness to NREM sleep (Fig 2C) and the total NREM sleep episodes
(Fig 2D) did not change, even though CNO induced fewer NREM sleep bouts of 1–2 minutes.
However, the number of prolonged NREM sleep episodes with durations between 4–16 minutes
was significantly increased (Fig 2E), resulting in a longer mean duration of NREM sleep (Fig 2F).
CNO administration promoted NREM sleep at the expense of REM sleep, significantly reducing
REM sleep bouts of all durations (Fig 2G). Electroencephalogram (EEG) power spectrum analysis
revealed that during the 7 hours after CNO injection, the average slow-wave activity (SWA)—a
commonly used quantitative measure of sleep intensity, indicated by an EEG power between 0.5
and 4 Hz within NREM sleep [28–30]—in CNO-injected rats increased by 11.0% compared with
the saline-injected controls. In contrast, the CNO-injected rats displayed a 9.6% decrease in the
power density of REM sleep during the theta band range of 6–10 Hz (Fig 2H and 2I).
The above results indicate that activation of RMTg neurons played an important role in
maintaining NREM sleep in rats.
In the saline group, a total of 8 c-Fos+ neurons were found in the RMTg of rats infected
with viral vectors encoding hM3Dq, indicating that RMTg neurons were not remarkably
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Fig 1. Pharmacogenetic activation of the hM3Dq-expressing rat rostromedial tegmental nucleus (RMTg) neurons. Schematic representation of the Cre-
independent adeno-associated virus (AAV) vectors expressing hM3Dq receptors under the control of hSyn promoter. hSyn, human synapsin promoter; WPRE,
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activated during the spontaneous sleep–wake cycle. When we analyzed distribution of the c-
Fos+ cells in the CNO group, we found that 78% of them expressed hM3Dq/mCherry (151 of
194) and that the other 22% were mCherry− (43 of 194). These c-Fos+/mCherry− neurons may
possibly be activated by CNO-induced sleep. Since the regulation of cell activity is very compli-
cated, the increased RMTg c-Fos expression induced by sleep promotion must be a compre-
hensive result, in which many neural circuits are involved.
Optogenetic stimulation of RMTg terminals inhibited midbrain DAergic
neurons
To explore the functional nature of the RMTg-to-midbrain DAergic connections, we
employed an optogenetic-assisted circuit mapping approach. Channelrhodopsin-2 (ChR2), a
blue light-gated cation channel, was expressed in RMTg neurons by injecting AAV-ChR2-m-
Cherry into the RMTg of Sprague–Dawley rats. After 3 weeks, acute coronal brain slices con-
taining the RMTg or VTA/SNc were prepared for in vitro patch-clamp recording (Fig 3A).
The expression of ChR2 allowed the activation of cell bodies within the RMTg and the selective
stimulation of terminals from the RMTg that projected to the VTA and SNc.
First, we found that there were dense mCherry+ terminals of RMTg neurons in VTA and
SNc, which showed anatomical connections between RMTg neurons and midbrain DAergic
neurons (Fig 3B). We then tested the responses of ChR2-expressing neurons within the RMTg
to optogenetic stimulation. Blue light pulses at 20 Hz evoked action potentials with high fidel-
ity and elicited robust photocurrents under voltage mode (Fig 3C). Next, cells in the VTA and
the SNc were patch clamped while blue light flashes were used to stimulate the axon terminals
of RMTg neurons. To identify the cell types of recorded midbrain neurons, we added biocytin
to the pipette solution and performed immunostaining using TH as a marker for DAergic neu-
rons after recording. We found that light-evoked inhibition could be recorded in TH-positive
neurons within the VTA and the SNc (Fig 3D and 3E), and the connected neurons were dis-
tributed throughout the rostrocaudal extent of the VTA/SNc (Fig 3F). In the cell-attached
patch mode, photostimulation (5-millisecond pulses, 20 Hz) of RMTg terminals in the VTA
or the SNc was sufficient to decrease the firing rate; in some cases, light application totally
inhibited the spikes of midbrain neurons, and the firing rate recovered immediately upon the
termination of photostimulation (Fig 3G and 3J). In the whole-cell voltage-clamp mode, light
evoked fast inhibitory postsynaptic currents (IPSCs) in VTA and SNc TH-positive neurons
with latencies less than 5 milliseconds in both cases (Fig 3H and 3K), indicating a direct inhibi-
tory connection between the terminals of RMTg neurons and midbrain TH-positive neurons.
Moreover, the light-evoked IPSCs were completely abolished by 100 μM picrotoxin (PTX, a
GABAAR antagonist; Fig 3I and 3L), indicating that these responses were mediated by GABA
released from axon terminals of RMTg neurons.
woodchuck hepatitis virus post-transcriptional regulatory element; CNO, clozapine-N-oxide; IP, intraperitoneal. (B) The coronal section shows the superimposed
virus-injected area in 9 rats numbered with the same color characters as the closed curves. The bilateral shaded areas indicate the rat RMTg locations. (C) mCherry
immunolabeling (red) indicates hM3Dq-expressing neurons of the RMTg. IPN, interpeduncular nucleus; ml, medial lemniscus. (D) Representative
photomicrographs of the RMTg depicting mCherry expression (red), γ-amino butyric acid (GABA) immunoreactivity (green), 4,6-diamidino-2-phenylindole
(DAPI, blue), and merge (yellow) images from a rat microinjected with Cre-independent AAV vectors containing hM3Dq. (E, F) CNO (E), not saline (F), drives c-
Fos expression in hM3Dq-expressing neurons in the RMTg. (G) Quantification of c-Fos staining in mCherry-expressing RMTg neurons after saline or CNO
injection in rats. p< 0.01 versus saline by unpaired t tests (n = 3, per group). (H) A typical example of voltage trace recorded from an hM3Dq+ rat RMTg neuron
during application of CNO in a brain slice. CNO application (horizontal bar) increased the action potential firing. (I) Merged image of mCherry and biocytin
showing a fluorescent view of the patched cell. Left panel: biocytin-labeled neuron; right panel: cell with green (biocytin; top), red (hM3Dq-mCherry; middle), and
yellow (merged; bottom) fluorescence. (J, K) Average membrane potential of RMTg hM3Dq+ neurons (J, n = 7 cells), but not hM3Dq− neurons (K, n = 5 cells), was
significantly increased by CNO application. The results from each cell are shown on the scatterplot. p< 0.01 versus saline by paired t tests. Underlying data can
be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g001
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Sleep promotion induced by RMTg activation was mimicked by inhibition
of VTA/SNc DAergic neurons in TH-Cre mice
The present study confirmed that midbrain DAergic neurons receive direct inhibitory inner-
vation from RMTg neurons, which is now known to be the predominant GABAergic control
for midbrain DAergic neuron activity. Furthermore, functional studies have revealed that the
roles of the RMTg are mediated by the modulation of DAergic neurons. Thus, we wondered
Fig 2. Pharmacogenetic activation of rostromedial tegmental nucleus (RMTg) neurons increased non-rapid eye movement (NREM) sleep in rats. (A, B)
Sleep–wake quantities following saline and clozapine-N-oxide (CNO) injection, including average hourly (A) and total sleep–wake amounts (B) during the post-
injection period (09:00–16:00 hours). (C–G) Sleep–wake architecture during the post-injection period (09:00–16:00 hours), including conversions between S
(NREM sleep), W (wakefulness), and R (REM sleep) stages (C), episode numbers of sleep–wake stages (D), number of NREM and REM sleep bouts with different
duration (E, G), and mean duration of sleep–wake stages (F). (H, I) Average slow-wave activity (SWA) of NREM sleep (H) and electroencephalogram (EEG) power
of REM sleep in the frequency range of 6–10 Hz (I) during the post-injection period (09:00–16:00 hours) following saline and CNO injection. p< 0.05, p< 0.01
versus saline by paired t tests. CNO (0.3 mg/kg) was given by intraperitoneal (IP) injection at 09:00 hours (n = 9). The horizontal open and filled bars on the x-axes
indicate the 12-hour light period and the 12-hour dark period, respectively. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g002
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Fig 3. Optogenetic activation of terminals from rostromedial tegmental nucleus (RMTg) neurons inhibited the firing of midbrain dopaminergic neurons.
(A) Schematic of the experiment. Adeno-associated virus–channelrhodopsin-2 (AAV-ChR2) was injected into the RMTg of Sprague–Dawley rats, and responses
were recorded in the midbrain (ventral tegmental area [VTA]/substantia nigra compacta [SNc]). (B) Representative images of dense mCherry+ terminals (red) of
RMTg neurons in VTA (top) and SNc (bottom). Tyrosine hydroxylase (TH, green) immunostaining was used to demarcate the VTA and SNc. (C)
ChR2-mCherry expressing neurons showed fidelity of spiking (top) following 20 Hz blue light illumination in current-clamp mode. This depolarization coincided
with inward current recorded under voltage clamp (bottom). (D, E) Fluorescence micrographs showing a recorded biocytin-filled neuron in the VTA (D) or the
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whether sleep control by the RMTg also occurs through the modulation of DAergic neuron
activity.
To specifically manipulate DAergic neuron activity, Cre-dependent AAVs (Fig 4A) were
microinjected into the VTA or SNc areas (Fig 4E) of TH-Cre mice to express the sequence of
hM3Dq or hM4Di, which was activated by CNO treatment; as a result, the DAergic neurons
were reversibly excited or inhibited, respectively. To detect whether AAVs could be expressed
specifically in DAergic neurons rather than in other kinds of neurons, hM4Di-expressing
AAVs combined with red fluorescent protein mCherry were microinjected into the VTA of
TH-Cre mice. Immunofluorescent staining of colocalization (yellow) of mCherry (red), DAPI
(blue), and TH (green) showed that 56% of TH-expressing neurons in the VTA coexpressed
hM4Di/mCherry (170 of 302) and that 79% of hM4Di/mCherry-positive neurons were cola-
beled with TH (170 of 214) (Fig 4B–4D), which validated the efficiency and specificity of this
targeting strategy for midbrain DAergic neurons.
To test the brain states in which the DAergic neurons were inhibited, we microinjected
Cre-inducible AAVs expressing hM4Di fused with red fluorescent protein into the target of
TH-Cre mice. The microinjection sites and AAV-hM4Di-infected areas were confirmed by
mCherry expression in the VTA (Fig 4F) and SNc (Fig 4H). Intraperitoneal injection of both
CNO and saline did not induce c-Fos expression in hM4Di-expressing mice (Fig 4G and 4I).
Next, we performed in vitro electrophysiological experiments to confirm the inhibitory effects
of CNO on hM4Di-expressing neuron activity. The recorded mCherry-expressing neuron dis-
played firing properties with hyperpolarization-activated cation current (Ih) (Fig 4J, top) that
were similar to the properties previously reported for DAergic neurons [31]. Whole-cell cur-
rent clamp recordings demonstrated that bath application of CNO (500 nM) inhibited the fir-
ing rate of a VTA hM4Di-expressing DAergic neuron (Fig 4J, bottom). These results indicated
that after AAV-hM4Di microinjection, DAergic neurons were inhibited by CNO in vivo and
in vitro.
When CNO was administered at 09:00 hours, the TH-Cre mice microinjected with AAV-
hM4Di into the VTA or SNc showed an increase in NREM sleep, a decrease in wakefulness,
and no change in REM sleep. Compared with the saline control, when VTA DAergic neurons
were inhibited, total NREM sleep at 4 hours following CNO treatment was increased by
25.6%, while wakefulness decreased by 36.9% (Fig 5A and 5B). Similarly, the inhibition of SNc
DAergic neurons by CNO administration induced a 3-hour increase of 45.5% in NREM sleep,
with a 37.8% decrease in wakefulness (Fig 5C and 5D). The number of prolonged NREM sleep
episodes with durations between 8 and 64 minutes showed a tendency of increase, which may
have caused the increase of NREM sleep when VTA DAergic neurons were inhibited using the
pharmacogenetic approach (Fig 5E). Similarly, inhibition of SNc DAergic neurons produced
an increase in the number of NREM sleep episodes lasting between 4 and 16 minutes (Fig 5G).
Although the amount of NREM sleep induced by pharmacogenetic activation of the RMTg
was mimicked by inhibiting midbrain DAergic neurons, the enhanced quality of NREM sleep
with higher SWA levels induced by activation of the RMTg was not demonstrated (Fig 5F and
5H).
SNc (E) that expressed TH. (F) The location of connected biocytin-filled neurons across the rostrocaudal extent of the VTA (blue dots) or the SNc (red dots). (G,
J) A typical cell-attached patch recording showed that brief blue light pulses totally suppressed spiking of DAergic neurons in the VTA (G) or SNc (J). (H, K)
Latency (left axis) and amplitude (right axis) of light-evoked inhibitory postsynaptic currents (IPSCs) in the VTA (H) or SNc (K) TH-positive neurons (n = 8 cells
for VTA or 11 cells for SNc from 6 rats). (I, L) Typical traces of postsynaptic currents from a VTA neuron (I) or a SNc neuron (L) evoked by blue light. The
evoked currents were completely abolished by application of picrotoxin (PTX) (100 μM; black lines). Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g003
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Fig 4. Pharmacogenetic inhibition of ventral tegmental area (VTA)/substantia nigra compacta (SNc) dopaminergic (DAergic) neurons in tyrosine hydroxylase
(TH)-Cre mice. Schematic representation of Cre-dependent adeno-associated virus (AAV) vectors expressing hM3Dq/hM4Di-mCherry under the control of human
synapsin (hSyn) promoter. WPRE, woodchuck hepatitis virus post-transcriptional regulatory element; CNO, clozapine-N-oxide; IP, intraperitoneal. (B) Microinjection of
AAV-DIO-hM4Di-mCherry into the VTA induced hM4Di expression (red). ml, medial lemniscus; SNc, substantia nigra, compacta; SNr, substantia nigra, reticular part.
(C) Representative photomicrographs of the VTA depicting mCherry expression (red), TH (green), and 4,6-diamidino-2-phenylindole (DAPI, blue) immunoreactivity
and merge images (yellow) from a TH-Cre mouse microinjected with Cre-dependent AAV vectors containing hM4Di. (D) Statistics of the coexpression of TH and
mCherry immunofluorescence of VTA neurons (n = 3, per group). (E) Drawings of superimposed AAV-injected area in the VTA (left, n = 8) and SNc (right, n = 8) of
TH-Cre mice with different colors. (F, H) Representative photomicrographs of mCherry expression after microinjection of AAVs containing hM4Di into the VTA (F)
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and SNc (H). (G, I) CNO (G, I; top) and saline (G, I; bottom) did not induce c-Fos expression in hM4Di-expressing DAergic neurons in VTA (G) or SNc (I). (J) In
TH-Cre mice, the firing property of a recorded VTA hM4Di/mCherry-positive DAergic neuron with hyperpolarization-activated cation current (Ih) (top) and CNO
perfusion inhibited its firing rate (bottom). Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g004
Fig 5. Pharmacogenetic inhibition of ventral tegmental area (VTA)/substantia nigra compacta (SNc) dopaminergic (DAergic) neurons promoted non-rapid
eye movement (NREM) sleep in tyrosine hydroxylase (TH)-Cre mice. (A, C) Time course changes of NREM and REM sleep and wakefulness after administration
of saline or clozapine-N-oxide (CNO) in hM4Di-expressing TH-Cre mice in the VTA (A, n = 8) and SNc (C, n = 8) DAergic neurons. (B, D) Total sleep–wake
amounts during 09:00–13:00 hours (B, VTA) or 09:00–12:00 hours (D, SNc) after administration of saline or CNO. (E–H) Number of NREM sleep bouts with
different duration (E, G) and average power density of NREM sleep (F, H) in 4 hours (E, F, VTA) or 3 hours (G, H, SNc) after saline or CNO injection in TH-Cre
mice. p< 0.05, p< 0.01 versus saline by paired t tests. CNO (1.0 mg/kg) was given by intraperitoneal (IP) injection at 09:00 hours. The horizontal open and filled
bars on the x-axes indicate the 12-hour light period and the 12-hour dark period, respectively. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g005
The rostromedial tegmental nucleus is essential for sleep
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002909 April 13, 2018 10 / 29
Sleep–wake effects of RMTg lesions in rats
In order to investigate whether the RMTg plays a role in physiological sleep promotion, bilateral
lesions were formed in the RMTg neurons by microinjection of ibotenic acid, a cell-specific neu-
rochemical toxin, using a glass microelectrode technique. After a recovery period, continuous
EEG was performed for 48 hours. We compared lesioned and saline-injected control animals for
sleep–wake parameters, including time spent in each sleep–wake state, bout numbers, average
bout durations, and SWA. On completion of EEG recordings, the lesion position and extent was
immunohistologically confirmed by neuron-specific nuclear-binding protein (NeuN) staining.
Compared with the intact neurons in the control rats, the animals with ibotenic acid-induced
lesions showed extensive cell loss within the RMTg. The lesion extent of each rat was outlined by
drawing the boundary of the NeuN-positive neuron population when the staining images had
been scaled by the same proportion as the referenced atlas in the same canvas (Fig 6A and 6B).
At 8 days after lesions, rats showed a 25.2% decrease in NREM sleep and a 47.8% decrease
in REM sleep along with a 35.9% increase in wakefulness during the 12-hour period from
04:00 to 16:00 hours (Fig 6C and 6D). Analysis of sleep architecture showed that the average
duration of NREM sleep was not shortened, and the REM sleep duration was prolonged in the
lesioned rats from 04:00 to 16:00 hours. However, the total number of episodes of NREM and
REM sleep was markedly decreased in the lesioned rats (Fig 6E and 6F). The rats with RMTg
lesions tended to have fewer NREM sleep bouts in the range of 10–50 seconds than controls,
although the difference was not statistically significant, and had significantly fewer NREM
sleep bouts between 1–2 minutes and REM sleep bouts between 10–50 seconds than controls
(Fig 6G and 6H). The lesioned rats also had fewer conversions from wakefulness to NREM
sleep, NREM sleep to REM sleep, and REM sleep to wakefulness (Fig 6I). Therefore, the
decreased NREM and REM sleep amount was mainly the result of a reduction in the number
of short fragments of NREM sleep (<2 minutes) and REM sleep (<1 minute) in the lesioned
rats. Across the 24-hour period, SWA was at the highest level—48.0% ± 2.5% and 38.6% ±
1.6% in control and lesioned animals, respectively—during 07:00–08:00, immediately after
light onset. The highest level of SWA in the NREM sleep was significantly lower in the lesioned
rats than in the control rats (p< 0.01). Then, SWA gradually decreased until immediately
before and after lights off, when it was at the lowest level (Fig 6J).
Similarly, at 16 days after RMTg lesions, the amount of sleep and wakefulness and sleep–
wake architecture differed significantly between the lesion and control groups. NREM sleep
decreased by 9.4%, and REM sleep decreased by 14.3%, with corresponding increases in wake-
fulness by 10.7% was observed in the lesioned rats in comparison with the controls over a
24-hour period (see S1A and S1B Fig). The lesioned rats had fewer episodes of NREM and
REM sleep and fewer conversions from wakefulness to NREM sleep, NREM sleep to REM
sleep, and REM sleep to wakefulness than the control rats (see S1C–S1E Fig). SWA in NREM
sleep during the hour immediately after lights turned on was also significantly lower in the
lesioned rats (42.1% ± 2.3%) than in the control rats (50.6% ± 2.9%) (see S1F Fig).
The loss of NREM and REM sleep in the RMTg lesion rats was not observed at 25 days after
neuron damage (see S2A and S2B Fig). There were no differences in episode bouts, durations,
or conversions among NREM and REM sleep and wakefulness between the lesioned and con-
trol rats (see S2C–S2E Fig). However, at 25 days after RMTg lesions, the rats still had lower
SWA levels in NREM sleep, similar to those at 8 and 16 days. SWA in NREM sleep during the
first hour of the light phase (34.9% ± 6.4%) was continually and markedly lower than that of
the control rats (48.0% ± 2.0%) (see S2F Fig).
The results suggest that the RMTg is involved in the initiation of NREM sleep, which is
compensated by some brain structures at 25 days after damage to RMTg neurons.
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Fig 6. Sleep and wake profiles on day 8 after inducing rostromedial tegmental nucleus (RMTg) lesions with ibotenic acid. (A) Diagrammatic drawing of
lesion extent with ibotenic acid in the total 13 lesioned animals whose electroencephalograms (EEGs) were successfully collected after 8 days (RL84, RL116,
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Furthermore, the RMTg maintains NREM sleep depth, and this effect lasts longer than that on
sleep initiation.
Effects of RMTg lesions on homeostatic regulation of sleep
Sleep homeostasis is primarily studied through sleep deprivation (SD) experiments [32]. Thus,
we performed 6-hour SD from 13:00 to 19:00 hours in control and lesioned rats and compared
their rebound sleep to determine the role of the RMTg in homeostatic regulation of sleep. The
control rats and rats with 8 days of RMTg lesions exhibited similar responses in their NREM
sleep during the subsequent recovery period following SD (Fig 7A and 7B). We calculated the
total time spent in NREM sleep for 2 hours after SD because the increase in NREM sleep was
maintained for 2 hours during the recovery period after 6-hour SD. From 19:00 to 21:00
hours, there was no difference between the control and lesioned rats in the baseline level of
NREM sleep, which increased by 57.6% and 128.2%, respectively, after 6-hour SD (Fig 7C). In
both groups, the increase in NREM sleep was mainly due to prolonged bout duration (Fig 7D).
To compare the rebound of SWA within NREM sleep after 6-hour SD in the control and
lesioned groups, the SWA data were analyzed using 2-way ANOVA followed by paired t tests.
The analysis revealed a significant increase in SWA in the control rats during the first 7 hours
(from 19:00 to 02:00 hours) following 6-hour SD (p = 0.041) compared with the baseline level.
In contrast, 6-hour SD induced no increase in SWA in the lesioned rats even during the first 2
hours (from 19:00 to 21:00 hours) immediately after SD (p = 0.394) compared with the base-
line level. There was no change from baseline in the mean SWA in control (33.1% ± 2.2%) or
lesioned (27.5% ± 2.7%) rats during the first 2-hour interval from 19:00 to 21:00 hours. After
6-hour SD, the average SWA increased by 38.2% ± 4.3% and 21.5% ± 4.2% from the baseline
levels to 46.1% ± 4.0% and 33.5% ± 3.7% in the control and lesioned rats, respectively (Fig 7E
and 7F). The magnitude of the increase in SWA after 6-hour SD was significantly lower in
lesioned rats than in control rats (p< 0.05, unpaired t test).
The above results showed that in the recovery period following 6-hour SD in RMTg
lesioned rats, the amount of NREM sleep rebounded normally, but the rebound of NREM
sleep depth was impaired. Therefore, the RMTg plays an important role in the homeostatic
regulation of NREM sleep.
Effects of local inhibition of RMTg neurons on sleep–wake behavior in rats
The RMTg is rich in μ receptors, and in vivo electrophysiological experiments have found that
morphine, a μ-receptor agonist, inactivates RMTg neurons [25, 33]. Therefore, to rapidly and
reversibly inhibit RMTg neurons, we bilaterally microinjected morphine through guide can-
nulas. After EEG recording, Nissl staining was performed to confirm the microinjection site.
Only samples in which the needle tips were located in the RMTg were included in data analysis
(Fig 8A). Under current-clamp conditions, morphine perfusion at 10 μmol/L (μM) was found
RL140, RL142, RL162, RL164, RL183, and RL170, n = 8), 16 days (RL140, RL142, RL164, RL170, RL150, RL154, RL187, and RL194, n = 8), 25 days (RL116,
RL164, RL183, RL187, RL194, and RL118, n = 6), and 8 days following 6-hour sleep deprivation (RL162, RL164, RL183, and RL170, n = 4) of lesions. The lesioned
rats were numbered with the same color characters as the closed curves. The bilateral shaded areas indicate the RMTg area. (B) Photographs of representative
coronal sections from a control (left) and a lesioned (right) rat by NeuN staining. The parts with red circles show the location of the RMTg. IPN, interpeduncular
nucleus; ml, medial lemniscus. (C) Hourly amount of non-rapid eye movement (NREM) and rapid eye movement (REM) sleep and wakefulness. (D) Total sleep–
wake amount during the 9-hour dark period (19:00–04:00 hours), the subsequent 12-hour period (04:00–16:00 hours) and the 3-hour light period (16:00–19:00
h). (E–I) Sleep–wake architecture during 04:00 to 16:00 hours. Mean duration (E) and total episode numbers (F) of NREM and REM sleep and wakefulness;
episode spectrum of NREM (G) and REM (H) sleep; transitions between S (NREM sleep), W (wakefulness), and R (REM sleep) stages (I). (J) Hourly slow-wave
activity (SWA) (expressed as percentage of delta power [0.5–4 Hz] in NREM sleep per hour) of NREM sleep. p< 0.05, p< 0.01 versus controls. Control
(n = 9); lesion (n = 8). The horizontal filled and open bars on the x-axes indicate the 12-hour dark period and the 12-hour light period, respectively. Underlying
data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g006
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Fig 7. Rats with RMTg lesions by ibotenic acid for 8 days showed a deficit in rebound of non-rapid eye movement (NREM) sleep quality in
response to 6-hour sleep deprivation (SD). (A, B) Time course of NREM sleep in control (A) and RMTg lesioned rats (B). Sleep was deprived
from 13:00 to 19:00 hours. (C, D) Amount of NREM sleep (C) and mean duration of NREM sleep (D) during 19:00–21:00 hours following 6-hour
SD. (E, F) Time course of slow-wave activity (SWA) (expressed as percentage of delta power [0.5–4 Hz] in NREM sleep per hour) from 19:00 to
07:00 hours following 6-hour SD in control (E) and RMTg lesioned rats (F). p< 0.05, p< 0.01 versus corresponding baseline using 2-way
ANOVA followed by paired t tests. Control (n = 6); lesion (n = 4). The horizontal open and filled bars on the x-axes indicate the 12-hour light and
the 12-hour dark period, respectively. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g007
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to decrease the firing rate and induce significant hyperpolarization of RMTg neurons from
−49.3 ± 1.3 to −56.3 ± 2.2 mV (p< 0.05). In some cases, morphine completely inhibited the fir-
ing of RMTg neurons within 1–2 minutes (Fig 8B and 8C). These results were consistent with
previous reports that opioids could inactivate RMTg neurons [33].
Fig 8. Microinjection of morphine in rat rostromedial tegmental nucleus (RMTg) decreased non-rapid eye movement (NREM) sleep in a dose-dependent
manner. (A) Nissl staining showed the implantation sites of the guide cannulas. (B, C) Morphine inhibited RMTg neurons in vitro. A typical trace showed that
morphine induced hyperpolarization and inhibited spontaneous firing of a neuron in the RMTg (B) and changes of membrane potentials of RMTg neurons under
whole-cell current-clamp with application of morphine. n = 4 cells, p< 0.05 versus baseline using 1-way ANOVA followed by least significant difference (LSD) (C).
(D) Time course of NREM and REM sleep and wakefulness during the light period (07:00–19:00 hours) in rats treated with artificial cerebrospinal fluid (ACSF) or
morphine at 09:00 hour. (E) Sleep–wake quantities following ACSF or morphine microinjection in rats during post-injection period (10:00–13:00 hours). p< 0.05,
p< 0.01 versus ACSF and #p< 0.05 versus 0.5 nmol/side morphine using 1-way ANOVA followed by LSD. (F–K) During the post-injection period (10:00–13:00
hours) after ACSF or morphine microinjection in rats, episode numbers of each stage (F); number of NREM (G) and REM (H) sleep bouts with different duration;
mean duration of each stage (I); stage transitions between S (NREM sleep), W (wakefulness), and R (REM sleep) stages (J); and slow-wave activity (SWA) of NREM
sleep (K). p< 0.05, p< 0.01 versus ACSF using unpaired t tests. MI, microinjection; Mor, morphine. ACSF (n = 6); morphine 0.5 nmol/side (n = 5); morphine 2
nmol/side (n = 5). The horizontal open bars on the x-axes indicate the 12-hour light period. Underlying data can be found in S1 Data.
https://doi.org/10.1371/journal.pbio.2002909.g008
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During the 3-hour post-microinjection of morphine at 2 nmol/side, the rats showed an
immediate 48.5% decrease in NREM sleep and a 93.1% decrease in REM sleep, with an
increase in wakefulness by 107.6% compared with the artificial cerebrospinal fluid (ACSF)
controls (Fig 8D and 8E). EEG architecture analysis showed that during the 3 hours after
microinjection of morphine at 2 nmol/side, although the episode numbers of NREM and
REM sleep did not change (Fig 8F), the longer fragments of NREM sleep with durations
between 1 and 4 minutes and longer fragments of REM sleep between 1 and 2 minutes were
significantly decreased (Fig 8G and 8H). As a result, the mean duration of NREM and REM
sleep was shortened compared with ACSF microinjection controls (Fig 8I). In addition, the
morphine-induced inhibition of RMTg neurons did not affect the number of stage shifts
between wakefulness and NREM sleep (Fig 8J). EEG power spectrum analysis revealed that the
power density of NREM sleep was significantly decreased in the rats microinjected in the
RMTg with 2 nmol/side morphine compared with the ACSF controls over the frequency
range of delta activity from 0.5 to 4 Hz during the 3 hours from 10:00 to 13:00 hours following
microinjection (p< 0.05) (Fig 8K). The above results suggest that the RMTg plays roles in the
maintenance of the duration and quality of NREM sleep.
Similar results were observed after pharmacogenetic inhibition of cells in the RMTg with Gi-
coupled DREADDs (see S3 Fig). When RMTg neurons were inactivated (see S4A and S4B Fig),
the rats showed a decrease in time spent in NREM sleep and a corresponding increase in time
awake, but no decrease in REM sleep (see S4C Fig). The decreased NREM sleep resulted mainly
from the reduction of NREM bout occurrence, particularly the number of shorter episodes with
durations between 10–110 seconds (see S4D and S4E Fig) and fewer conversions from wakeful-
ness to NREM sleep (see S4F Fig) following CNO injections. These results suggest that the RMTg
plays a role in the initiation of NREM sleep. However, the changes in the mean duration and
SWA level of NREM sleep did not differ significantly between saline-treated rats and CNO-treated
rats (see S4G and S4H Fig). The decrease in NREM sleep without any change in SWA induced by
pharmacogenetic inhibition of the RMTg using hM4Di was mimicked by selective pharmacoge-
netic activation of VTA/SNc DAergic neurons using hM3Dq in TH-Cre mice (see S5 Fig).
Discussion
Using pharmacogenetic activation and neurotoxic lesions, as well as microinfusion and phar-
macogenetic inactivation approaches, the present study found that RMTg neurons were essen-
tial for physiological NREM sleep. After RMTg neurons were damaged, the rats had reduced
NREM sleep, which was mainly due to the decreased number of short-duration bouts and fewer
transitions from wakefulness to NREM sleep. The results suggest that the RMTg is involved in
the initiation of NREM sleep. Moreover, the RMTg mediates the maintenance of NREM sleep
quality. SWA in the NREM sleep of the control and lesioned rats was prominent at lights on,
when sleep pressure is highest, and gradually decreased as sleep progressed, which was in line
with previous reports [30, 32]. However, the highest level of SWA in the RMTg-lesioned rats
was significantly and continuously weaker than that in the control animals. NREM sleep quality
was impaired by RMTg lesions, and the impairment lasted longer than the reduction in the
amount of NREM sleep, which returned to baseline at 25 days after lesions. Therefore, the
RMTg is essential to maintaining SWA at the peak level in NREM sleep; in contrast, its role in
maintaining NREM sleep quantity can be fulfilled by other brain regions.
Although lesion formation is a widely used approach in neuroscience research, it has some
limitations, such as causing irreversible damage to neurons and fibers of passage, which is not
a natural physiological situation, and as a result, it is not possible to regulate neuronal activity
reversibly [34]. Moreover, functional recovery may be seen, and the effects of lesions are
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confounded by secondary compensatory changes in response to the damage [35]. Comple-
mentary to the research on permanent neurotoxic lesions, temporary inactivation studies will
help to clarify the engagement of the RMTg in the physiological regulation of sleep. We
observed that the inactivation of RMTg neurons by both intra-RMTg injections of morphine
and the Gi-coupled DREADD approach markedly reduced NREM sleep duration, which con-
firms the necessity of RMTg for the control of NREM sleep. The present study also shows that
the normal neuronal activities of RMTg are necessary for the maintenance of NREM sleep, as
demonstrated by the reduction in the numbers of longer bouts of NREM sleep with mor-
phine-RMTg injection, as well as for the initiation of NREM sleep, as shown by the decreased
numbers of short-duration bouts of NREM sleep and fewer transitions from wakefulness to
NREM sleep with Gi-coupled DREADDs and neurotoxic lesions. The role of the RMTg in the
promotion of NREM sleep is suggested again by the pronounced increase in NREM sleep
duration with higher SWA levels after pharmacogenetic activation of RMTg neurons.
Most likely, the different effects of the RMTg on sleep architecture and sleep depth arise
from differences in pharmacological and pharmacogenetic effects. The lesion method is an
excellent approach, but it does not exclude a neuromodulatory role. Another conventional
pharmacological intervention of microinfusion as well as the pharmacogenetic method with
Gi-coupled AAV vectors that has developed rapidly over the past decade can be used to inacti-
vate neurons. Intra-RMTg injection of morphine inhibits neurons by stimulating μ-opioid
receptors and is likely to inhibit many more cells within the nucleus and diffuse to adjacent
nontargeted areas, whereas the DREADD method is mainly used in the local nucleus to inhibit
modified muscarinic receptors (M-Rs), especially with lower doses of AAVs, and generally
produces mild effects. Moreover, the downstream signaling pathways of morphine and CNO
(ligand for M-Rs) are also different.
It is worth noting that the vast majority of mCherry-positive cells in our study were con-
fined to the RMTg (see S6 Fig). However, some labeled cells were found ventrally in the IPN. It
has been reported that lesions of the bilateral fasciculus retroflexus, a major input to the IPN,
result in reduced REM sleep [36]. Another study found that the Gscl (a
homeobox transcription factor, Goosecoid-like) knockout mice exhibited a decrease in REM
sleep and an increase in NREM sleep [37]. These findings indicate that the normal function of
IPN is required for wakefulness and REM sleep. The neighboring dorsal and median raphe
also had a small number of infected neurons. The main neurons in dorsal and median raphe
are serotonergic neurons, which are sufficient for inducing wakefulness. Drugs that increase
serotonin tone, such as selective serotonin reuptake inhibitors, generally increase wakefulness
in both humans and rodents [38]. In all, the effects of the expression of hM3Dq/hM4Di spread
outward somewhat are not linked to the NREM sleep promotion of RMTg neurons.
Sleep is an inactive state, characterized by the cessation of locomotion, reduced responsive-
ness, and easy reversibility [28]. From this point of view, the present results were in agreement
with Lavezzi et al., who found that the activation of RMTg neurons through bilateral infusions
of the GABAA receptor antagonist bicuculline suppressed locomotor activity in rats [39].
REM sleep was also inhibited during CNO-induced NREM sleep in rats with DREADD
activation of RMTg neurons. Why REM sleep was so strongly inhibited is unclear, but one
explanation may be that the effect of NREM sleep-promotion is too pronounced to be
completely compensated by wakefulness alone. In a previous study, similar REM sleep reduc-
tion was observed when activation of the parafacial zone markedly induced NREM sleep [40].
It is also possible that RMTg GABAergic neurons project to and inhibit REM sleep-promoting
PPT and LDT neurons [38]. However, considering that lesions or inactivation of the rat RMTg
did not markedly affect REM sleep quantity, we feel that the RMTg does not play an important
role in the physiological control of REM sleep.
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Homeostatic control of sleep, 1 of 2 sleep regulation processes, is the increased propensity
for sleep during prolonged wakefulness [41]. Animals may compensate for sleep loss by an
increased amount of NREM sleep and SWA in NREM sleep [28]. Our study showed that
6-hour SD induced a 2-hour increase in NREM sleep, which was similar to previous studies,
which found that NREM sleep was significantly above the corresponding baseline in the first
2-hour interval after 6-hour SD [42, 43]. However, in the present study, NREM sleep intensity
significantly increased in control rats, whereas the RMTg-lesioned rats showed a reduced
response of sleep homeostasis, as indicated by the lack of enhanced delta EEG power in NREM
sleep after 6-hour SD. Several previous studies showed the same results. Rats with nucleus
accumbens core lesions showed reductions in SWA rebound, but not in sleep duration
response, after 6-hour SD [43], and the A1-R (a kind of adenosine receptor) knockout mice
responded similarly following 3-hour SD [44].
SWA in NREM sleep is considered to be functionally involved in sleep–wake homeostasis.
However, the neuronal mechanisms and neurochemical factors that drive these homeostatic
responses are largely unknown [7, 32]. Studies have suggested that SWA is generated in the
cerebral cortex and thalamus [38], and the basal forebrain is another important structure for
sleep homeostasis [45]. The DRN and PPT nucleus are important target nuclei of RMTg [15].
Inhibition of DRN neurons by inhibition of calmodulin-dependent kinase II or damage with
3,4-methylenedioxymethamphetamine was found to significantly enhance NREM sleep and
delta power density during NREM sleep [46, 47]. In addition, activation of cholinergic LDT
neurons suppressed slow EEG activity during NREM sleep [48]. Moreover, the VTA and SNc,
which are major strong outputs of RMTg, have efferent and afferent connections with the
DRN, LDT, locus coeruleus, lateral and posterior hypothalamus, basal forebrain, and thalamus
[49]. Collectively, the downstream nuclei may be involved in the circuit through which the
RMTg regulates sleep homeostasis. Further studies are needed to clarify the inconsistency of
RMTg’s effects on the 2 aspects of homeostasis regulation.
RMTg is widely recognized as a brake for the DAergic system. Early electrophysiological find-
ings, which showed that VTA and SNc DAergic neurons do not change their firing rates across
the sleep–wake cycle [50, 51] and that there is no change in the time spent in electrocortical wak-
ing in animals with electrolytic lesions of the catecholamine-containing neurons of the VTA and
SNc [52], suggest that DAergic neurons are not involved in the regulation of sleep–wake states
[7]. Meanwhile, some evidence suggests that DA signals are associated with sleep promotion [49,
53]. Since DAergic neurons are mainly distributed in the VTA and SNc, we directly manipulated
the activity of midbrain DAergic neurons using pharmacogenetic methods to observe their effects
on sleep–wake behavior. We found that selective inhibition of VTA/SNc DAergic neurons pro-
moted NREM sleep, which was also observed with activation of RMTg neurons. In contrast, selec-
tive activation of VTA/SNc DAergic neurons produced an increase in wakefulness. The current
results are in agreement with a recent finding that optogenetic stimulation or inhibition of VTA
DAergic neurons initiates and maintains wakefulness or increases NREM sleep, respectively [10].
Conclusion
We find that the RMTg is essential for NREM sleep and homeostatic regulation. Since the
RMTg exerts major inhibitory control over the midbrain DAergic system, we hypothesize that
the RMTg regulates sleep–wake behavior through the modulation of DAergic neuron activity.
However, we cannot exclude the possibility that other RMTg GABAergic projected targets also
contribute to the roles of the RMTg in sleep–wake behavior.
For further study, we will use transgenic VGAT (vesicular GABA transporter)-Cre mice to
specifically target the GABAergic neurons in order to expand on our findings in rats that
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RMTg neurons are necessary for sleep and use pharmacogenetic and optogenetic manipula-
tions together with polysomnographic recordings to elucidate the role of the downstream ele-
ments of GABAergic RMTg neurons in the control of sleep.
There is evidence that sleep, especially NREM sleep with high levels of EEG delta power, is
important not only for neurobehavioral functions such as memory consolidation [54] but also
for peripheral physiological functions such as the maintenance of normal glucose homeostasis
[55, 56]. Thus, the current results suggest that the RMTg may be considered as a potential
intervention for prolonging NREM sleep duration and improving sleep quality to maintain
human health. Moreover, the data obtained in the present study enrich our understanding of
how the brain regulates sleep–wake behavior and provide a potential target for understanding
the roles of DA in the physiological regulation of sleep–wake states as well as in the pathologic
process of sleep disturbances. Our results will inform the development of potential therapeutic
targets against sleep disorders in DA-implicated mental illness.
Methods
Ethics statement
All experimental procedures involving animals were approved by the Committee on the Ethics
of Animal Experiments of School of Basic Medical Sciences, Fudan University, with license
identification number 20150119–067. The animals were anesthetized with an IP injection of
chloral hydrate before surgery or killing. The animals were put on the heating pad until they
woke up from anesthesia after surgery. During the postoperative recovery period, the animals
were observed every day, and the sawdust was kept clean. Every effort was made to minimize
animal suffering or discomfort and to reduce the number of animals used.
Animals
Male Sprague–Dawley rats (280–370 g) were obtained from the Laboratory Animal Center,
Chinese Academy of Sciences (Shanghai, China). Adult male TH-Cre mice and non-Cre-
expressing littermate mice (8–16 weeks old, 25–30 g) were also used. The animals were housed
in individual cages at an ambient temperature (22 ± 0.5˚C) with relative humidity of 60% ± 2%
in an automatically controlled 12:12-hour light/dark cycle (lights on at 07:00 hours, illumina-
tion intensity approximately 100 lux), with free access to food and water.
AAV generation
The AAVs of serotype rh10 for AAV-hSyn-DIO-hM3Dq-mCherry, AAV-hSyn-DIO-hM4Di-
mCherry, and AAV-hSyn-DIO-ChR2-mCherry were generated by tripartite transfection
(AAV-rep2/caprh10 expression plasmid, adenovirus helper plasmid, and pAAV plasmid) into
293A cells. After 3 days, the 293A cells were resuspended in ACSF, freeze-thawed 4 times, and
treated with benzonase nuclease (Millipore) to degrade all forms of DNA and RNA. Subse-
quently, the cell debris was removed by centrifugation, and the virus titer in the supernatant
was determined using an AAVpro Titration Kit for Real Time PCR (Takara). The final viral
concentrations of the transgenes were 1 × 1012–2 × 1012 genome copies/mL. Aliquots of viral
vectors were stored at −80˚C before stereotaxic injection.
Surgery
To induce lesions in the RMTg, rats were anesthetized with chloral hydrate (10% in saline, 360
mg/kg) and immobilized in a Stereotaxic Alignment System (RWD Life Science, Shenzhen,
China). Ibotenic acid (1% in saline, 200 nL/side; Sigma, St. Louis, Missouri, United States) was
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bilaterally injected through a glass pipette (glass stock: 1 mm in diameter; tip: 10–20 μm) with
nitrogen gas pulses of 20–40 psi using an air compression system [57] into the RMTg accord-
ing to the atlas [58] (coordinate relative to bregma: AP −6.8 mm; ML ± 0.3 mm; DV −8.4 mm)
for 5–10 minutes. After leaving the pipette in the brain for an additional 5 minutes, the pipette
was slowly retracted. Control rats received 200 nL/side saline.
For microinjection of morphine in the RMTg, rats were implanted with 2 guide cannula
(30 gauge). The cannulas were inserted at stereotaxic coordinates based on the rat brain atlas
[58] (coordinate relative to bregma: AP −6.8 mm; ML ± 0.3 mm; DV −7.4 mm). The 2 cannu-
las were fixed to the skull with dental cement and 3 stainless steel screws for anchorage [59].
In order to manipulate neuronal activity, we used hM3Dq or hM4Di that was selectively
activated or inhibited by the pharmacologically inert agent CNO [60]. Under anesthesia with
chloral hydrate (10% in saline, 360 mg/kg), a burr hole was made, and a fine glass pipette con-
taining AAVs carrying Cre-independent hM3Dq, hM4Di, or ChR2 was lowered bilaterally
into the rat RMTg (coordinate relative to bregma: AP −6.8 mm; ML ± 0.3 mm; DV −8.4 mm).
The AAV vectors were delivered with 300 nL/side.
Mice were anesthetized with chloral hydrate (5% in saline, 720 mg/kg) and then placed in a
stereotaxic frame so that the head was fixed. After opening a burr hole, a fine glass pipette con-
taining AAV carrying Cre-dependent hM3Dq/hM4Di (Taiting, Shanghai, China) was bilater-
ally lowered into the VTA (coordinate relative to bregma: AP −3.4 mm; ML ± 0.3 mm; DV
−4.0 mm) or SNc (coordinate relative to bregma: AP −3.4 mm; ML ± 1.2 mm; DV −4.0 mm)
according to the atlas[5]. The AAV vectors (50 nL/side) were delivered over a 5-minute period
per hemisphere. After an additional 10 minutes, the pipette was slowly withdrawn.
Following ibotenic acid or saline injection (or guide cannula implantation) or after 2 weeks
of recovery from virus injection, the rats were implanted with EEG and electromyography
(EMG) electrodes for polysomnographic recordings. The implant consisted of 2 stainless steel
screws (1-mm diameter) inserted through the frontal (AP +2 mm; ML +3 mm) and parietal
(AP −4 mm; ML +3 mm) bones, and a stainless steel screw (1.5-mm diameter) inserted in the
left frontal bone (AP +3 mm; ML −3 mm) as a reference electrode. All of the above positions
were coordinately relative to the bregma [58]. The mice were recovered for 2 weeks after virus
injection before electrodes were implanted. Two stainless steel screws (1-mm diameter) were
inserted through the skull into the cortex (AP +1 mm to the bregma; AP +1 mm to the lambda;
ML +1.5 mm to the midline) [61] and served as EEG electrodes.
Two Teflon-coated, stainless steel wires were bilaterally placed into both trapezius muscles
for EMG recordings in rats or mice. All electrodes for the rats or mice were attached to a
connector and fixed to the skull with dental cement. The animals were then allowed to recover
on a heating pad until awakening from anesthesia [62].
Sleep recording and vigilance state analysis
After a 1-week recovery period from EEG electrode implantation, the animals were transferred
to the recording room and habituated to the recording cables and conditions for 2–3 days. Fol-
lowing this habituation period, 48 hours of EEG/EMG recordings were performed on all the
animals. The data collected during the first 24 hours served as baseline, and the second 24
hours served as experimental data.
Morphine hydrochloride, a nonselective μ-opioid receptor agonist, diluted in ACSF, was
injected at 09:00 hours through a syringe connected with a lengthened flexible pipe under red
illumination; thus, the rats could freely move or have rest without irritant body touch, disturb-
ing noises, and natural light. A syringe that was designed with an oblique tip for easy aligning
was gently and smoothly inserted into the hollow and straight guide cannula (O.D. = 0.6 mm).
The rostromedial tegmental nucleus is essential for sleep
PLOS Biology | https://doi.org/10.1371/journal.pbio.2002909 April 13, 2018 20 / 29
A volume of 0.5 μL morphine was injected in each side by microinjector at a slow and constant
speed for 0.5 minutes. Injection was made unilaterally in sequence. After the end of each injec-
tion, the syringe was left for an additional 3 minutes for complete local absorption. The control
group was injected with ACSF.
In the DREADD experiment, saline was administered IP at 09:00 hours on day 1 of the
EEG recording. On the next day, CNO (LKT Laboratories, Minneapolis, Minnesota, US) was
dissolved in saline before use and injected at 09:00 hours at 1 mg/kg for mice (0.1 mL/10 g) or
0.3 mg/kg for rats (1 mL/100 g).
Cortical EEG and EMG signals were amplified, filtered (EEG, 0.5–30 Hz; EMG, 20–200
Hz), digitized at a sampling rate of 128 Hz, and recorded using VitalRecorder (Kissei Comtec,
Nagano, Japan). When complete, polygraphic recordings were automatically scored offline by
10-second epochs as waking, NREM sleep, and REM sleep using SleepSign according to stan-
dard criteria. Defined sleep–wake stages were examined visually and corrected if necessary
[57].
SD
SD was achieved by gentle handling that included tapping the cage, introducing novel objects
into the cage, or removing the rat from the cage when behavioral signs of sleep were observed.
Rats were deprived of sleep during the light phase for 6 hours from 13:00 to 19:00 hours.
Undisturbed rats that served as a control group were never disturbed when they were sponta-
neously awake, feeding, or drinking in the same time period as the corresponding 6-hour SD
group [30, 42].
Immunohistochemistry
On completion of EEG recordings of the rats with lesions or morphine microinjection, the
rats were anesthetized with chloral hydrate (10% in saline, 360 mg/kg), with 150–200 mL saline
followed by 500 mL 4% paraformaldehyde (PFA) in PBS through the heart. The brains were
removed, post-fixed for 4–5 hours at 4˚C in 4% PFA, and then equilibrated in phosphate buffer
containing 10%, 20%, and 30% sucrose solution at 4˚C. The brain sections were serially cut
in the coronal plane at 30 μm on a freezing microtome (CM1950, Leica, Wetzlar, Germany),
protected in cryoprotectant solution, and stored at −20˚C until further processing for
immunostaining.
For verification of ibotenic-acid-induced brain lesions, one series of tissues was processed
for NeuN staining. Brain sections were incubated in primary antibody in PBS containing
Tween-20 (PBST) (mouse anti-NeuN, 1:50,000; Millipore, Bedford, Maryland, US) overnight,
and then staining was revealed using the avidin–biotin complex method (ABC kit SC-2017;
Santa Cruz Biotechnology, Santa Cruz, California, US). The sections were incubated for 2
hours in biotinylated secondary antibody in PBST (1:500), followed by incubation with avi-
din–biotin–horseradish peroxidase (HRP) conjugate and staining with 3,3-diaminobenzidine
tetrahydrochloride (DAB). Sections were then mounted, dried, dehydrated, and cover slipped.
Only samples in which the lesion sites were confined to the RMTg were included in data
analysis.
For confirmation of the microinjection site of morphine, one series of sections was sub-
jected to Nissl staining. Brain sections were mounted on adhesive slides, dried naturally for 2
consecutive days, and stained by cresyl violet method. Sections were washed in water and PBS
successively, incubated in 0.1% cresyl violet for 15 minutes, differentiated in graded ethanol,
and cleared in xylene before being cover slipped. All sections containing a cannula-insertion
site were compared with a rat brain atlas to confirm the 3-dimensional coordinates of the site
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relative to bregma. Only experiments in which the tip of the microinjection cannula was
located above the RMTg were included in data analysis [59].
The AAV vectors were linked with a red fluorescent protein mCherry; therefore, the viral
injection site was determined by mCherry expression. Induction of c-Fos, the protein of an
immediate early gene, is supposed to be an indicator of neuronal activity [63]. Thus, whether
the virus-infected neurons were activated or inhibited could be determined through c-Fos
expression. After EEG/EMG recording, the animals were injected with saline or CNO (0.3 mg/
kg for rats; 1 mg/kg for mice). Ninety minutes later, the animals were anesthetized and per-
fused, and the brain coronal sections were prepared. The brain tissue sections were rinsed in
0.1 M PBS (3 times, 5 minutes/each wash) and then incubated in rabbit anti-c-Fos primary
antibody (1:5,000; Millipore) diluted in PBST for 48 hours. The tissues were washed 3 times in
PBS and incubated with Alexa Fluor 488-conjugated donkey anti-rabbit secondary antibody in
PBST (1:1,000; Invitrogen, Carlsbad, California, US) for 2 hours in the dark. After being
washed in PBS, the sections were mounted on glass slides, cover slipped using FluoroGuard
Mounting Medium, and kept at 4˚C before imaging [40]. Colocalization of mCherry and c-
Fos expression was observed by confocal microscopy. Localization of the rat RMTg and mouse
VTA and SNc were confirmed by staining and reference to the brain atlas.
For double immunofluorescence staining of TH/mCherry or GABA/mCherry, brain sections
were incubated with a rabbit antibody against TH (1:3,000; Millipore) or GABA (1:1,000; Invitro-
gen) in PBST over night at 4˚C. The sections were then rinsed and incubated in a donkey anti-
rabbit Alexa Fluor 488-conjugated secondary antibody (1:1,000; Invitrogen) at room temperature
for 2 hours in the dark. After 3 washes in PBS, sections were incubated in 4,6-diamidino-2-pheny-
lindole (DAPI; 1:3,000; Invitrogen) for 10 min at room temperature. Finally, sections were washed
in PBS and mounted on glass slides using FluoroGuard Mounting Medium.
Cell counting
For quantification of the colocalization of mCherry-expressing RMTg neurons in rats and
VTA/SNc DAergic neurons in mice microinjected with hM3Dq/hM4Di-containing vectors
and other histological markers (GABA, c-Fos, TH), the area used for counting was demarcated
by cells that were labeled by mCherry. All cell counting was conducted blindly on 3 × 2 tiled
confocal images of the target area. For each rat or mouse, brain sections were analyzed bilater-
ally [64].
Electrophysiological experiments
To investigate whether CNO manipulates the activity of AAV-infected cells or RMTg has an
inhibitory projection to midbrain DAergic neurons, male Sprague–Dawley rats, 20–30 days
old weighing 50–60 g, were microinjected with AAV vectors carrying Cre-independent hsyn–
hM3Dq (hM4Di, ChR2)-mCherry under anesthesia with chloral hydrate into the RMTg, and
TH-Cre mice were microinjected with AAV vectors carrying Cre-dependent hsyn–hM3Dq/
hM4Di–mCherry into the VTA or SNc. Slices containing the RMTg of the rats or VTA/SNc of
TH-Cre mice were prepared from the animals 3 weeks after AAV microinjection or from male
Sprague–Dawley rats, 20–30 days old weighing 50–60 g, without AAV injection to investigate
whether morphine inhibited RMTg neurons in vitro. The RMTg or VTA/SNc was identified
according to stereotaxic coordinates [58, 61].
Coronal slices of the rats (280-μm thick) were cut using a vibratome (VT-1200S; Leica) in
ice-cold sucrose-based ACSF, bubbled with 95% O2 and 5% CO2, containing 230 mM sucrose,
2.5 mM KCl, 3 mM MgSO4, 1.25 mM NaH2PO4, 26 mM NaHCO3, 0.5 mM CaCl2, and 10 mM
D-glucose. The slices were allowed to recover for at least 1 hour in a holding chamber with
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ACSF without sucrose in a water bath (32˚C) before recording. For preparation of the mouse
brain slices, the coronal slices were cut at 300-μm thickness in ice-cold glycerol-based ACSF,
which was different from the rats, containing 260 mM glycerol, 5 mM KCl, 1.25 mM KH2PO4,
1.3 mM MgSO4, 0.5 mM CaCl2, 20 mM NaHCO3, and 10 mM glucose.
Coronal slices were transferred to the recording chamber, where they were held down with
a platinum ring. Carbonated ACSF with 95% O2 and 5% CO2 flowed through the bath (2 mL/
minute). Patch pipettes were pulled from thick-walled borosilicate glass capillaries (1.5-mm
outer diameter, 0.84-mm internal diameter, Sutter Instruments, San Rafael, California, US)
using a 2-step vertical puller (PC-10; Narishige, Japan). Pipette resistance was typically 4–7
MO when filled with internal solution containing 120 mM potassium gluconate, 20 mM KCl,
1 mM MgCl2, 0.16 mM CaCl2, 10 mM HEPES, 0.5 mM EGTA, 2 mM Mg-ATP, and 0.5 mM
NaGTP. RMTg or VTA/SNc neurons were identified under visual guidance using a fixed-stage
upright microscope (BX-51; Olympus, Tokyo, Japan) fitted with a 40 × water immersion
objective lens. The image was detected with an infrared sensitive charge coupled device camera
(U-TV1X-2; Olympus) and displayed on a screen in real time. The output signals were ampli-
fied (Molecular Devices, Eugene, Oregon, US), filtered at 5 kHz, and digitized at 20 kHz using
a National Instruments digitization board (NI-DAQmx, PCI-6052E; National Instruments,
Austin, Texas, US). Neurons were current clamped to record spontaneous action potentials
and/or membrane potentials. The series resistance and input resistance were monitored
throughout the cell recording, and data were discarded when either of the 2 resistances
changed by>20% [57, 65]. To visualize the recorded cells in the RMTg, biocytin (0.2%) was
included in the pipette solution to confirm the position of patched cells. Slices were fixed
immediately after recording in 4% formaldehyde for 2 hours and then immersed in 0.3%
PBST. Slices were incubated in Fluor-488-conjugated streptavidin (Invitrogen, 1:2,000, 12
hours at 4˚C). Sections were mounted on slides using FluoroGuard Antifade Reagent (Bio-
Rad, Hercules, California, US) and visualized under an Olympus microscope.
For the optogenetic experiment, whole-cell and cell-attached recordings were made from
RMTg or VTA/SNc DAergic neurons. ChR2 was stimulated by 473-nm light delivered via an
optical fiber coupled to a laser source (Guang Teng, Shanghai, China). For recording light
evoked inhibitory synaptic currents, the internal solution contained 105 mM potassium gluco-
nate, 30 mM KCl, 4 mM ATP-Mg, 10 mM phosphocreatine, 0.3 mM EGTA, 0.3 mM GTP-Na,
and 10 mM HEPES. In the voltage-clamp mode, cells were held at −70 mV. When needed,
25 μM d-(-)-2-amino-5-phosphonopentanoic acid (d-APV), 5 μM NBQX, and 100 μM PTX
were added to block NMDA, AMPA, and GABAA receptors, respectively. The internal solu-
tion also contained 0.2% biocytin. To test for expression of TH, brain slices were incubated in
rabbit anti-TH antibody (1:2,000, Millipore) containing 3% normal donkey serum (v/v), 0.5%
Triton X-100 (v/v) for 24 hours at 4˚C. This was followed by incubation with Alexa Fluor
488-conjugated donkey anti-rabbit (1:800; Invitrogen) and Alexa Fluor 405 streptavidin
(1:1,000, Invitrogen) for 12 hours at RT.
Statistical analysis
The sum of sleep and wakefulness and other sleep architecture parameters in the RMTg-
lesioned and control rats were compared using unpaired t tests. The sleep–wake profiles
among groups with different doses of morphine microinjection and vehicles were assessed
using 1-way ANOVA followed by least significant difference tests. The hourly durations of
each stage and SWA analyses were compared using 2-way ANOVA (repeated measures) fol-
lowed by unpaired t tests. Two-way ANOVA (repeated measures) followed by paired t tests
were conducted to analyze the sleep rebound induced by 6-hour SD in rats.
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For viral microinjection, the sum of sleep and wakefulness and other sleep architecture
parameters after CNO or saline injection as well as membrane potentials of rat RMTg neurons
before and after bath application of CNO were compared using paired t tests. The hourly dura-
tion of each stage of sleep and wake profiles was compared using 2-way ANOVA (repeated
measures) followed by paired t tests.
For GABA, c-Fos, or TH immunohistochemistry analysis, each group consisted of data
obtained from 3 rats or TH-Cre mice; as a result, a total of 3 bilateral sections containing target
area were analyzed for each animal. The quantification results were compared using unpaired
t tests between CNO and saline control groups.
All results were expressed as the mean ± SEM. We analyzed the data using Prism 5.0
(GraphPad software, San Diego, California, US). In all cases, p< 0.05 was taken as the level of
significance.
Supporting information
S1 Data. The excel spreadsheet (in separate sheets) contains the underlying numerical data
used to generate all graphs and histograms in the manuscript.
(XLSX)
S1 Fig. Sleep and wake profiles on day 16 after rostromedial tegmental nucleus (RMTg)
lesions with ibotenic acid. (A) Hourly amount of NREM and REM sleep and wakefulness. (B)
Total sleep–wake amount during the 12-hour dark (19:00–7:00 hours) and the 12-hour light
(07:00–19:00 hours) and the 24-hour period. (C–E) Sleep–wake architecture over 24 hours.
Mean duration (C) and episode numbers (D) of NREM and REM sleep and wakefulness; tran-
sitions between S (NREM sleep), W (wakefulness), and R (REM sleep) stages (E). (F) Hourly
slow-wave activity (SWA) of NREM sleep. p< 0.05, p< 0.01 versus control. Control
(n = 10); lesion (n = 8). The horizontal filled and open bars on the x-axes indicate the 12-hour
dark period and the 12-hour light period, respectively.
(TIF)
S2 Fig. Sleep and wake profiles on day 25 after rostromedial tegmental nucleus (RMTg)
lesions with ibotenic acid. (A) Hourly amount of NREM and REM sleep and wakefulness. (B)
Total sleep–wake amount during 12-hour dark (19:00–07:00 hours) and 12-hour light (07:00–
19:00 hours) and the 24-hour period. (C–E) Sleep–wake architecture over 24 hours. Mean
duration (C) and episode numbers (D) of NREM and REM sleep and wakefulness; transition
numbers between S (NREM sleep), W (wakefulness), and R (REM sleep) stages (E). (F) Hourly
slow-wave activity (SWA) of NREM sleep. p< 0.05 versus control. Control (n = 7); lesion
(n = 6). The horizontal filled and open bars on the x-axes indicate the 12-hour dark period and
the 12-hour light period, respectively.
(TIF)
S3 Fig. Expression of hM4Di receptors in the rostromedial tegmental nucleus (RMTg)
mapped on coronal atlas drawings at four brain levels. The gray shading highlights the
RMTg as shown in the Paxinos and Watson (2007) rat brain atlas. The expression of hM4Di
receptors in the RMTg from each animal is outlined. n = 7 rats. IPN, interpeduncular nucleus;
Pn, pontine nuclei.
(TIF)
S4 Fig. The hM4Di-mediated inhibition of rostromedial tegmental nucleus (RMTg) neu-
rons decreased NREM sleep in rats. (A) Coronal section shows the superimposed virus-
injected area in seven rats numbered with the same color characters as the closed curves. The
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bilateral shaded areas indicate the rat RMTg locations. (B) A typical trace showed that Cloza-
pine-N-oxide (CNO) application (horizontal bar) induced hyperpolarization and inhibited
spontaneous firing of a neuron in the RMTg under whole-cell current-clamp. (C) Time course
of NREM and REM sleep and wakefulness during the 12-hour light period (07:00–19:00
hours) in rats treated with saline or CNO at 09:00 hour. (D–H) During 1-hour post-injection
period (9:00–10:00 hour) after saline or CNO injection in rats, episode numbers of each stage
(D); number of NREM sleep bouts with different duration (E); transition numbers between S
(NREM sleep), W (wakefulness), and R (REM sleep) stages (F); mean duration of each stage
(G); slow-wave activity (SWA) of NREM sleep (H). p< 0.05, p< 0.01 versus saline by
paired t test. CNO (0.3 mg/kg) was given by intraperitoneal (IP) injection at 09:00 h (n = 7).
The horizontal open bar on the x axes indicate the 12-hour light period.
(TIF)
S5 Fig. Activation of ventral tegmental area (VTA)/substantia nigra compacta (SNc) dopa-
minergic (DAergic) neurons decreased NREM sleep in tyrosine hydroxylase (TH)-Cre
mice. (A, B) Drawings of superimposed AAV injection sites in the VTA (A, n = 8) and SNc (B,
n = 8) of TH-Cre mice with different colors. (C) Clozapine-N-oxide (CNO) evoked vigorous
firing of a VTA mCherry-positive neuron in a TH-Cre mouse. (D, E) c-Fos (green) was
expressed in mCherry-positive (red) neurons after injection of 1 mg/kg CNO (D, E, top), but
not injection of saline (D, E, bottom) in the VTA (D) and SNc (E). (F, G) Statistics of the co-
expression of c-Fos and mCherry immunofluorescence of VTA (F) and SNc (G) DAergic neu-
rons from TH-Cre mice (n = 3, per group). (H, J) Time course changes of NREM and REM
sleep and wakefulness after intraperitoneal (IP) injection of saline or CNO (1.0 mg/kg) at
09:00 hour in hM3Dq-expressing TH-Cre mice in the VTA (H) and SNc (J). (I, K) Amount of
each stage in 4 hours (I, VTA) or 3 hours (K, SNc) after saline or CNO injection. p< 0.05,
p< 0.01 versus saline by paired t test. The horizontal open and filled bars on the x-axes indi-
cate the 12-hour light and the 12-hour dark period, respectively.
(TIF)
S6 Fig. Expression of hM3Dq receptors in the rostromedial tegmental nucleus (RMTg)
mapped on coronal atlas drawings at four brain levels. The gray shading highlights the RMTg
as shown in the Paxinos and Watson (2007) rat brain atlas. The expression of hM3Dq receptors in
RMTg from each animal is outlined. n = 9 rats. IPN, interpeduncular nucleus; Pn, pontine nuclei.
(TIF)
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